Overview

A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy Participants

Status:
Completed
Trial end date:
2018-09-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the bioequivalence between lorcaserin XR tablets manufactured in Kawashima and lorcaserin XR tablets manufactured in Zofingen.
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Inc.